Sektor Protalix BioTherapeutics, Inc.

Aktien

A2PWSL

US74365A3095

PLX

Pharmazeutika

Markt geschlossen - 22:00:00 04.11.2026 Perf. 5 T Veränd. 1. Jan.
2.690 USD +3.07% Intraday Chart für Protalix BioTherapeutics, Inc. +6.32% +49.44%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
+3.07%+6.32%-0.74%+15.95%+49.44%+12.55%+45.41%+129.91%-37.15% 210 Mio.
+0.61%+10.62%+24.07%+26.45%+31.95%+58.16%+149.73%+432.56%+1’866.43% 1’255 Mrd.
+3.81%+2.82%+7.92%+8.61%+33.52%+48.35%+82.58%+67.41%+140.22% 641 Mrd.
+3.09%+2.95%+12.18%+20.29%+29.03%+39.10%+108.48%+150.77%+427.52% 505 Mrd.
+1.25%-0.78%+14.52%+11.21%+20.63%+52.56%+66.87%+7.44%+77.77% 381 Mrd.
+3.93%+6.02%+4.20%+17.68%+42.85%+82.28%+45.44%+69.55%+157.33% 357 Mrd.
+2.10%+4.26%+15.40%+7.84%+22.50%+34.93%+61.10%+75.57%+94.72% 303 Mrd.
+1.92%+9.37%+18.15%+21.95%+1.70%+13.43%+36.55%+50.15%+216.25% 286 Mrd.
+3.73%+6.82%+18.72%+26.29%+46.19%+61.48%+77.31%+119.36%+253.85% 249 Mrd.
+4.19%+9.68%+20.55%+33.04%+42.15%+42.96%+113.85%+158.83%+143.14% 208 Mrd.
+5.57%+9.90%+14.65%-5.66%-12.31%-9.55%-58.30%-22.03%+140.88% 179 Mrd.
+2.63%+3.32%+10.76%+23.01%+23.65%+24.86%-1.50%-31.30%+3.01% 171 Mrd.
+3.44%+5.38%+8.78%+16.64%+21.10%+28.88%+45.94%+190.39%+606.71% 135 Mrd.
+4.02%+4.29%+4.97%-1.96%+19.00%+39.48%+21.53%+8.14%+27.84% 126 Mrd.
+6.98%+10.59%+18.53%+29.29%+30.37%+30.37%+136.20%+376.94%+725.25% 117 Mrd.
+3.85%+11.91%+18.77%+12.89%+1.67%-3.27%-1.46%-6.80%+16.34% 109 Mrd.
+3.42%-1.74%+6.21%-1.02%+3.59%+7.57%+35.43%-3.73%-2.70% 98.3 Mrd.
-4.39%+14.04%+26.59%+22.58%+20.57%+44.91%+13.93%+42.72%+176.98% 97.67 Mrd.
+13.11%+24.24%+35.98%+368.59%+776.16%+937.25%+233.26%-25.31% - 91.2 Mrd.
+0.87%+4.12%+9.90%+5.62%+22.72%+34.63%+2.80%-29.47%+62.95% 72.58 Mrd.
Durchschnitt +1.88%+3.87%+14.51%+32.96%+61.32%+79.05%+60.76%+88.05%+268.28% 269.03 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt +1.36%+4.01%+15.79%+23.70%+39.51%+59.39%+83.55%+157.97%+593.09%
  1. Börse
  2. Aktien
  3. A2PWSL Aktie
  4. Sektor Protalix BioTherapeutics, Inc.